World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
39586
World Ranking
9186
National Ranking
4740

Overview

Nadine Tung is affiliated with Beth Israel Deaconess Medical Center in the United States. Their research focuses primarily on oncology, genetics, and cancer-related fields within medicine and biochemistry, genetics, and molecular biology.

The main fields of study for Tung include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their subfields of study highlight areas such as:

  • Oncology
  • Genetics
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Tung's research covers several key topics related to cancer, including:

  • BRCA gene mutations in cancer
  • PARP inhibition in cancer therapy
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology

Among recent significant publications authored or co-authored by Tung are:

  • TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes, 2020, Journal of Clinical Oncology
  • Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline, 2020, Journal of Clinical Oncology
  • PARP inhibition in breast cancer: progress made and future hopes, 2022, npj Breast Cancer

In addition to personal publications, Tung frequently collaborates with other researchers. The most frequent co-authors include:

  • Sara M. Tolaney
  • Ian E. Krop
  • Eric P. Winer
  • Antonio C. Wolff
  • Judy E. Garber

The venues where Tung publishes regularly emphasize oncology and cancer research. These frequent publication venues are:

  • Journal of Clinical Oncology
  • Cancer Research
  • Breast Cancer Research and Treatment
  • npj Breast Cancer
  • British Journal of Cancer

Best Publications

  • Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

    Mark Robson;Seock Ah Im;Elżbieta Senkus;Binghe Xu

  • Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

    Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans

  • Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

    Daniel P. Silver;Andrea L. Richardson;Aron C. Eklund;Zhigang C. Wang

  • Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

    Melinda L. Telli;Kirsten M. Timms;Julia Reid;Bryan Hennessy

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation

    Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch

  • Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

    Kelly Metcalfe;Henry T. Lynch;Parviz Ghadirian;Nadine Tung

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

    Amy P.M. Finch;Jan Lubinski;Pål Møller;Christian F. Singer

  • OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

    M.E. Robson;N. Tung;P. Conte;S.-A. Im

  • Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents

    Nicolai J. Birkbak;Nicolai J. Birkbak;Zhigang C. Wang;Zhigang C. Wang;Ji Young Kim;Aron C. Eklund

  • Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel

    Nadine Tung;Chiara Battelli;Brian Allen;Rajesh Kaldate

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

    Nadine Tung;Nancy U. Lin;John Kidd;Brian A. Allen

  • Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

    Steven A. Narod;Marie Pierre Dubé;Jan Klijn;Jan Lubinski

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate

    Theresa A. Proia;Patricia J. Keller;Patricia J. Keller;Piyush B. Gupta;Ina Klebba;Ina Klebba

  • BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

    Roxana Moslehi;Roxana Moslehi;William Chu;Beth Karlan;David Fishman

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

Frequent Co-Authors

Judy Garber
Judy Garber Harvard University
Steven A. Narod
Steven A. Narod University of Toronto
Susan L. Neuhausen
Susan L. Neuhausen City Of Hope National Medical Center
Jan Lubinski
Jan Lubinski Pomeranian Medical University
Susan M. Domchek
Susan M. Domchek University of Pennsylvania
Henry T. Lynch
Henry T. Lynch Creighton University
Beth Y. Karlan
Beth Y. Karlan University of California, Los Angeles
Eitan Friedman
Eitan Friedman City University of New York
Jeffrey N. Weitzel
Jeffrey N. Weitzel Natera (United States)
Olufunmilayo I. Olopade
Olufunmilayo I. Olopade University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and allied health pathways is a smart move for anyone interested in healthcare careers. If pursuing medical school isn't your ideal route, there are diverse online degree programs and certifications that can help you start or advance a healthcare career.

For those interested in managing patient data, consider a health information management bachelor degree online. These programs teach both technical and leadership skills, preparing graduates for fast-growing roles in healthcare administration.

If you're looking for a quick entry into the healthcare field, earning the cheapest medical coding certification online can lead to rewarding work in medical billing offices, clinics, or hospitals.

Nursing also remains a leading career option. Many students seek the cheapest np school to become nurse practitioners—an advanced, high-demand profession. Additionally, prospective nurses often ask how much does online nursing school cost to plan for a flexible and affordable path.

These online healthcare programs offer accessible routes to meaningful medical careers, combining quality training with cost-effective education options.

Best Scientists Citing Nadine Tung

Trending Scientists

Recently Published Articles